The U.S. Food and Drug Administration (FDA) said it is aware that Boston Scientific Corporation (NYSE: BSX) has alerted customers to remove certain AXIOS stents and electrocautery-enhanced delivery ...

Boston Scientific has issued an FDA earning letter recommending certain stents and electrocautery enhanced delivery systems be removed from where they are used or sold. Affected products include 1,660 ...

Add Yahoo as a preferred source to see more of our stories on Google. Boston Scientific's headquarters is in Marlborough, Massachusetts. (Courtesy of Boston Scientific) This story was originally ...

The FDA has classified Boston Scientific’s removal of certain Axios Stent and Electrocautery-Enhanced Delivery Systems as a Class I recall, the agency’s most serious designation. The recall stems from ...

Boston Scientific has issued a recall letter to users of the Axios stent after FDA linked the device to three deaths and 167 serious injuries. The deaths were linked to use cases of the stent that ...